Tissue Engineering Part A - Table of Contents

Correction to: BMP-3 Promotes Matrix Production in Co-cultured Stem Cells and Disc Cells from Low Back Pain Patients by Hingert D, Barreto Henriksson H, Baranto A, and Brisby H. Tissue Eng Part A 2019;26(1–2):47–56. DOI: 10.1089/ten.tea.2019.0125

Tissue Engineering Part A, Volume 26, Issue 5-6, Page 373-373, March 2020.

Tissue Engineering Part A - Table of Contents

2h

Bioprinting 101: Design, Fabrication, and Evaluation of Cell-Laden 3D Bioprinted Scaffolds

Tissue Engineering Part A, Volume 26, Issue 5-6, Page 318-338, March 2020.

Tissue Engineering Part A - Table of Contents

10h

Three-Dimensional Multilayered Microstructure Using Needle Array Bioprinting System

Tissue Engineering Part A, Volume 26, Issue 5-6, Page 350-357, March 2020.

Tissue Engineering Part A - Table of Contents

10h

Endothelial/Mesenchymal Stem Cell Crosstalk Within Bioprinted Cocultures

Tissue Engineering Part A, Volume 26, Issue 5-6, Page 339-349, March 2020.

Tissue Engineering Part A - Table of Contents

10h

Silk-Reinforced Collagen Hydrogels with Raised Multiscale Stiffness for Mesenchymal Cells 3D Culture

Tissue Engineering Part A, Volume 26, Issue 5-6, Page 358-370, March 2020.

Tissue Engineering Part A - Table of Contents

10h

Mark above section as read

 International Journal of Nanomedicine

Applications of Inorganic Nanomaterials in Photothermal Therapy Based on Combinational Cancer Treatment

International Journal of Nanomedicine

2h

Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy

International Journal of Nanomedicine

3h

Mark above section as read

 Latest Results for Clinical and Translational Imaging

Radiolabelled Trastuzumab PET/CT imaging: a promising non-invasive tool for the in vivo assessment of HER2 status in breast cancer patients

Abstract Purpose In patients with breast cancer, the overexpression of human epidermal growth factor receptor 2 (HER2) is associated with a worse prognosis and a better response to target therapy with monoclonal antibody, such as trastuzumab. HER2 status is usually revealed by immunohistochemistry (IHC) and/or fluorescence in situ hybridization (FISH) on tumour tissue sample. Recently, PET/CT with radiolabelled trastuzumab has been described...

Latest Results for Clinical and Translational Imaging

2h

Role of [ 18 F]-FDG PET in patients with atypical parkinsonism associated with dementia

Abstract Purpose The present review aims to discuss indications for the use of [18F]-FDG PET in patients with APS associated with dementia as emerged in the EANM/EAN joint recommendations for its use in dementia. New lines of evidence emerged after the EANM/EAN consensus have here been systematically reviewed. Methods We searched in the databases...

Latest Results for Clinical and Translational Imaging

2h

Mark above section as read